Issue 55, 2020

Synthetic dimeric-drug phospholipid: a versatile liposomal platform for cancer therapy

Abstract

An amphiphilic dimeric-podophyllotoxin (PODO) phospholipid was synthesized to assemble into liposomes as a combination of prodrug and nanocarrier. The results have demonstrated that the cell membrane-like delivery system possessed an improved cellular uptake and favorable antitumor efficacy with reduced side-effects. This strategy provides a new effective platform in drug delivery for cancer chemotherapy.

Graphical abstract: Synthetic dimeric-drug phospholipid: a versatile liposomal platform for cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
20 May 2020
Accepted
02 Jun 2020
First published
05 Jun 2020

Chem. Commun., 2020,56, 7621-7624

Synthetic dimeric-drug phospholipid: a versatile liposomal platform for cancer therapy

L. Ling, H. Yu, M. Ismail, Y. Zhu, Y. Du and J. Qi, Chem. Commun., 2020, 56, 7621 DOI: 10.1039/D0CC03589K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements